Bio Developments


NIH launches study of COVID-19 vaccine allergic reactions

By Rachel Arthur

The US National Institutes of Health (NIH) has started a clinical trial to determine whether people who are highly allergic, or have a mast cell disorder, are at increased risk of allergic reactions to the Moderna and Pfizer COVID-19 vaccines.


GSK to help manufacture Novavax COVID-19 vaccine

By Rachel Arthur

GSK will help manufacture up to 60 million doses of Novavax’s COVID-19 vaccine from its facility at Barnard Castle in the UK, with doses to be distributed in the country.

© GettyImages/stefanamer

Cytiva diagnostics design lab goes live in China

By Jane Byrne

Cytiva has opened a new diagnostics design lab in Tonglu, its manufacturing site close to Shanghai in East China, where it has been making filtration products for many years.

© GettyImages/alphaspirit

UK deal sees consolidation of two players in the iPSC space

By Jane Byrne

Axol Biosciences, a UK provider of human induced pluripotent stem cells (iPSC) derived cells, media, and characterization services, has merged with Scotland based, Censo Biotechnologies, a cell biology CRO with expertise in iPSC-related technologies.


Merck to help manufacture J&J COVID-19 vaccine

By Rachel Arthur

Merck’s US facilities will help manufacture Johnson & Johnson’s COVID-19 vaccine: which a $268.8m injection from the US government helping it adapt existing facilities for COVID-19 vaccines and medicines.